Back to Blog

Case Study - Charting the Next Step in Hip Replacement Surgeries

Formus Labs exists to facilitate better outcomes for patients undergoing joint replacement surgery. By equipping surgeons with advanced, AI-driven software that streamlines the pre-operative planning process, we empower them to deliver optimal results.

This recent case study overseen by the head of our clinical advisory board, Dr. Paul Monk, provides a compelling real-world example of how our software improves outcomes in even the most challenging of cases.

Read the full case study here »

More from the Lab

Formus Labs Hip Platform Receives FDA Clearance!

Formus Labs today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Formus Hip as the first “automated radiological image processing software” for hip replacement pre-op planning.

Read Story

Internationally Renowned Orthopaedic Surgeon Thought Leaders Join Formus Labs’ Clinical Advisory and Development Board.

Formus Labs, creator of the world's first automated 3D, AI-enabled pre-operative planner for joint replacement surgeries, today announces the expansion of its clinical advisory board. Three global thought leaders in the field of arthroplasty, Dr. J. Bohannon Mason, Dr. Atul Kamath and Dr. James A. Germano will help shape the next generation of Formus Labs’ innovative planning technology and will support the company’s expansion into new markets.

Read Story

Formus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy

Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement surgeries, today announced it has hired Polly Teevan as Chief Marketing Officer. Teevan will oversee global commercial and marketing strategy, and lead Formus to expand its presence in the US and international markets leveraging her deep customer relationships, industry knowledge and commercial experience.

Read Story

Subscribe for the latest news and product updates

We will never share your email address with third parties.